Nu Skin Enterprises NUS
NYSE NUS
$4.47 -0.06 (-1.21%)
As of: Oct 1, 2026 · 11:48 AM EDT

Nu Skin Enterprises (NUS) Non-Current Deferred Tax Liability (2010 - 2016)

Updated

Nu Skin Enterprises (NUS) recorded Non-Current Deferred Tax Liability of $643,000 in Q4 2016, down 96.0% from $16.18 million a year earlier.

Analysis

Nu Skin Enterprises (NUS) Non-Current Deferred Tax Liability (2010 - 2016) Analysis & Trends

Starting with Q4 2010, Nu Skin Enterprises' Non-Current Deferred Tax Liability history includes 7 quarters.

  • Annual Non-Current Deferred Tax Liability has a five-year compound annual growth rate of -43.4% (FY2011 to FY2016).
  • Across earlier years, Non-Current Deferred Tax Liability came in at $16.18 million in FY2015 (+1.0%), $16.02 million in FY2014 (+14.8%), $13.95 million in FY2013 (+358.9%) and $3.04 million in FY2012 (-72.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 337.81 Bn 293.80 Bn 10.28 Bn
2 Colgate Palmolive 68.01 Bn 63.06 Bn 3.30 Bn
3 Kenvue 33.93 Bn 29.54 Bn 2.30 Bn
4 Estee Lauder Companies 33.63 Bn 21.70 Bn 2.74 Bn
5 Kimberly Clark 32.41 Bn 29.73 Bn 1.60 Bn
6 Church & Dwight 22.35 Bn 20.88 Bn 693.90 Mn
7 Clorox 9.80 Bn 8.24 Bn 804.00 Mn
8 e.l.f. Beauty 5.95 Bn 4.92 Bn 398.84 Mn
9 Reynolds Consumer Products 4.56 Bn 4.22 Bn 245.00 Mn
10 Nu Skin Enterprises 220.51 Mn -664.12 Mn 218.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 643,000.00
Dec 31, 2015 16.18 Mn
Dec 31, 2014 16.02 Mn
Dec 31, 2013 13.95 Mn
Dec 31, 2012 3.04 Mn
Dec 31, 2011 11.07 Mn
Dec 31, 2010 11.24 Mn
API Access

Nu Skin Enterprises Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=NUS&period=max&api_key=YOUR_API_KEY